In this episode, Dr. Sanjay Juneja is joined by Mika Newton, CEO of xCures, to explore how AI is transforming the future of medicine. Together, they discuss tackling critical challenges like resource shortages, improving patient triaging, and leveraging data for smarter, faster decision-making. Mika shares his unique insights on how technology is reshaping healthcare systems and the exciting opportunities ahead. Don’t miss this engaging conversation—and stay tuned for a surprising reveal at the end!
Join Dr. Sanjay Juneja, known as the OncDoc, as he discusses the complex intersection of endocrinology and oncology with Dr. Afreen Shariff, an expert endo-oncologist from Duke University. This episode explores the often-overlooked endocrine side effects of cancer treatments, such as steroids and immune therapies, and how they impact patient quality of life. Dr. Shariff shares insights on managing hormonal imbalances, the importance of specialized care, and how platforms like Citrus Oncology are democratizing access to expert opinions and care. Discover how patients can better navigate the challenges of cancer treatment and thrive, supported by comprehensive, multi-specialty care. If you or a loved one are facing cancer treatment, this episode is essential listening.
In this episode of the Target Cancer Podcast, Dr. Sanjay Juneja sits down with Dr. Tim Showalter, Chief Medical Officer at Artera, to explore the transformative role of AI in personalizing cancer treatment. Dr. Showalter shares insights on how advanced AI tools are helping clinicians make more precise decisions, reducing overtreatment, and improving patients’ quality of life. Together, they discuss the moral and medical challenges of balancing aggressive cancer therapies with patient-centered care and the promise of AI in guiding better, data-driven outcomes.
In this engaging episode of the 'Target: Cancer Podcast,' Dr. Sanjay Juneja discusses the future of healthcare data with Therasa Bell, President, CTO, and co-founder of Kno2. Covering themes of healthcare inefficiencies, the importance of data sharing, and the critical need for innovation, this conversation dives deep into ways to tackle pressing concerns such as the aging population, provider shortages, and the sustainability of healthcare systems. You'll discover why data is seen as an underlying theme essential for solving these inherent issues and what measures are being taken at state and federal levels to improve the situation.
In this eye-opening episode, Dr. Sanjay Juneja teams up with leading experts Dr. Jason Fung and Dr. Thomas Seyfried to reveal the shocking truth about what really drives cancer growth. Forget everything you thought you knew—this isn’t just about genetics! They dive into the powerful connection between diet, insulin, and metabolism, and how controlling sugar and inflammation might hold the key to stopping cancer in its tracks. If you’ve ever wondered whether cancer can be "starved," this is the conversation you need to hear. Tune in for a mind-blowing discussion that could revolutionize cancer treatment!
Dr. Lim takes us through the evolution of personalized cancer therapy, starting from animal trials and advancing to human treatments. He explains how artificial intelligence is playing a critical role in creating precise and effective treatment plans in oncology. Explore the impact of AI in transforming cancer care by offering more personalized therapies, and how precision medicine is shaping the future of patient outcomes.
Join Dr. Sanjay Juneja as he talks with Dr. Sam Blackman about advancements in Pediatric Neuro-Oncology. Dr. Blackman shares his journey from philosophy to medicine, discusses innovative treatments for pediatric brain cancer, and explores the role of AI in neuro-oncology. Discover insights into the latest therapies and the future of brain cancer treatment for children in this episode. Gain a deeper understanding of the challenges and breakthroughs in treating pediatric brain tumors.
In this episode of the Target: Cancer Podcast, Dr. Sanjay Juneja dives deep into the latest developments in colorectal cancer with Michael Sapienza, CEO of the Colorectal Cancer Alliance. Michael shares his personal journey from professional musician to leading cancer advocate, inspired by his mother’s battle with the disease. Discover the urgent need for innovative treatments and how advancements in AI and data sharing can revolutionize colorectal cancer care. Learn about cutting-edge screening methods, the critical importance of early detection, and the ongoing efforts to improve funding and research for colorectal cancer prevention.
The podcast episode features Dr. Sanjay Juneja interviewing Dr. Robert Den, a Harvard and Yale-trained physician and radiation oncologist. Dr. Den discusses the importance of trust in the patient-physician relationship and its impact on cancer treatment decisions. He emphasizes the need for personalized care, considering patients' individual circumstances and goals. Dr. Den introduces the innovative "DaRT" (Diffusing Alpha Radiation Therapy) technology, which targets tumors with alpha radiation, demonstrating promising results across various cancer types. He explains how this approach can offer new hope and treatment options, especially for patients with challenging cancer cases. The conversation highlights the potential of DART therapy to improve patient outcomes and quality of life.
Dr. Chris Apfel explores innovative AI technology in cancer treatment, emphasizing early detection and personalized therapies. By utilizing real tissue testing to determine optimal drug responses, this method aims to enhance patient outcomes. Discover how this advancement is transforming cancer care and advancing precision medicine. Join Dr. Apfel on the Target: Cancer Podcast to delve into the future of customized treatments.
Discover the future of healthcare with Dr. Daniel Kraft on the Target: Cancer Podcast. Explore AI, wearables, and digital health in cancer care, and the potential of multiomics data and predictive analytics to revolutionize patient outcomes. Join the discussion on integrating cutting-edge advancements into everyday practice and navigating the evolving healthcare landscape. Don't miss this riveting exploration of technology, medicine, and innovation.
Investigative reporter Kristina Marusic delves into the connection between environmental exposures and cancer risk, sharing her sister's diagnosis and the effects of everyday chemicals. She emphasizes reducing pesticide exposure, filtering air and water, and using safer personal care products. Marusic advocates for regulatory changes and encourages listeners to urge lawmakers to prioritize cancer prevention. Tune in to discover how small lifestyle changes can significantly lower cancer risk.
Dr. David Braun discusses the exciting advancements in cancer vaccines and immunotherapy. He explains how the immune system can be harnessed to target and eliminate cancer cells, particularly in kidney cancer. He also discusses the potential for preventive vaccines and the future of curative treatments for cancer. This episode offers a fascinating glimpse into the cutting-edge research and possibilities in cancer immunotherapy.
Dr. Amit Kumar discusses the groundbreaking concept of a vaccine for cancer. He explains how they have identified "retired proteins" that are only produced during specific periods of life, such as lactation, and reappear when cancer cells arise. By vaccinating individuals after they no longer need these proteins, the immune system can be trained to target and destroy cancer cells. Dr. Kumar shares their progress in developing a vaccine for breast cancer and other types of cancers as well.
Dr. Sanjay Juneja interviews David Hysong and Katherine Arline from Shepherd, a precision oncology platform. They discuss the limitations of traditional cancer treatment guidelines and the need for a more personalized approach. Shepherd uses multiomic data, including RNA sequencing, to assess a patient's unique tumor characteristics and recommend tailored therapies. They also consider collateral medications and potential side effects.
Dr. Sanjay Juneja interviews Dr. Musti Kadhim about the exciting advancements in cancer treatment and the role of AI in improving patient care. They discuss the challenges of treating pancreatic and glioblastoma cancers, the potential of hypofractionation in radiation therapy, and the use of AI in precision medicine. Dr. Kadhim also explains the importance of data sharing and the ethical considerations surrounding AI in healthcare.
In this episode, we will discuss about the role of free circulating tumor DNA testing in early cancer detection, the current limitations of existing cancer screening modalities and the need for more proactive approaches to cancer care. Dr. Venstrom explains how Grail's technology works, using a blood test to detect abnormal patterns of DNA shedding from tumors. He emphasizes the importance of the cancer signal of origin and how it can guide targeted diagnostic and therapeutic interventions.
In this episode, Dr. Sanjay Juneja and Dr. David Penberthy discuss the role of radiation in cancer care and its effectiveness. Dr. Penberthy explains the different types of radiation therapy and how they are used to treat various types of cancer. They also explore the potential of combining radiation with immunotherapy and the exciting advancements in the field, the importance of a multidisciplinary approach to cancer treatment and the need for ongoing research and innovation.
In this episode, Dr. Sanjay Juneja discusses the impact of herbal supplementation, dietary supplementation, and diets on cancer outcomes. He is joined by Dr. Krystle Zuniga and Dr. Laura Kerns, who provide valuable insights based on their expertise in cancer nutrition. The episode covers topics such as the importance of protein and vitamins, the role of mushrooms and supplements and the benefits of a plant-based diet, also addresses common questions about red meat, dairy, and the gut microbiome.
Dr. Sanjay Juneja and rhinologist Dr. Henry Barham delve into taste receptors' intriguing role in cancer control and immune health. They examine t2r receptors, uncovering their ties to innate immunity and anti-cancer properties. Dr. Barham shares insights on bitterness sensitivity, COVID-19 outcomes, and a taste test for personalized diets and immune stimulation. This episode provides a fresh perspective on the significance of taste receptors in overall health.